Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (0)

Interim Study Shows That Intestinal Barrier Produces Weight Loss and Type 2 Remission

Jun 26, 2008

GI Dynamics estimates that the cost of inserting the liner, which is also easily removed endoscopically, is one-third that of gastric bypass surgery.

An impermeable liner inserted non-surgically into a portion of the small intestine produces rapid weight loss and remission of type 2 diabetes, according to a Montana endocrinologist.

At the recent 68th Annual Scientific Sections of the American Diabetes Association in San Francisco, Dr. Christopher Sorli, an endocrinologist at the Billings Clinic in Billings, Montana, reported the results of a test of EndoBarrier, an intestinal liner developed by GI Dynamics in Massachusetts.

The randomized study involved 18 type 2 participants. Twelve of the test subjects were given the liner endoscopically. The remaining six subjects also underwent an endoscopic procedure, but did not receive the liner.

The aim of the study was to determine EndoBarrier’s ability to create a physical barrier between food and the intestinal wall, mimicking the effects of gastric bypass surgery without the need for and drawbacks of actual surgery.

Diabetes researchers theorize that gastric bypass or barrier causes hormonal changes that lower metabolism. The result is weight loss and the re-establishment in type 2s of normal blood glucose levels.

One week after receiving the device, the type 2 patients experienced an immediate reduction in pre- and post-meal blood glucose levels. Dr. Sorli reported that some of them were able to completely stop taking their diabetes medications.

Dr. Sorli’s study is one of several randomized prospective trials of EndoBarrier now underway worldwide. Such trials involve determining a method for analyzing data before the trial begins—in this case, monitoring blood glucose levels, hormonal balances and weight—and then randomly assigning the treatment or a placebo to study participants.

The trials are double-blind: Neither the subjects nor the researchers know who is receiving what treatment.

GI Dynamics estimates that the cost of inserting the liner, which is also easily removed endoscopically, is one-third that of gastric bypass surgery.

Read an abstract of Dr. Sorli’s presentation

Watch a video interview with Dr. Sorli


Categories: Bariatric Surgery, Blood Glucose, Diabetes, Diabetes, Food, New Cure Research, Research, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Jun 26, 2008

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.